UEF Neurodegeneration - Myohanen Lab

02.08.2021 -
Our research group is focused on studying the mechanisms and drug targets in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, aiming to develop a disease-modifying therapy.

Biomarkers for Neurodegenerative Disorders

Research focus: pathogenesis of Alzheimer's research, particularly search for new biomarkers for neurodegenerative diseases.

Biomarkers for neurodegenerative diseases are needed for early diagnosis, follow-up of the progression of the disease and monitoring of therapeutic responses...

Neurobiology of disease

24.10.2017 -
The main goal of our research is to understand the mechanisms that lead to neurodegenerative diseases and to identify novel therapeutic approaches for them. We are interested in the effects of environmental factors (such as air pollution and viral infections) and lifestyle factors on brain healt...

Redox signaling (Anna-Liisa Levonen group)

Nrf2 is a transcription factor mainly involved in combating cellular stress caused by reactive oxygen and nitrogen species. However, Nrf2 is also involved in cancer and cardiometabolic diseases, making it an essential drug target.

Biomedical MRI

Magnetic resonance techniques have shown great success for non-invasive detection of structural, metabolic and functional abnormalities in progressive pathologies.

Clinical Alzheimer Research

Clinical Alzheimer Research groups have a wide expertise in clinical and population based cohorts, risk factors, neuropsychology, biomarkers, genetics, brain imaging, and clinical interventions and trials in AD and mild cognitive impairment.

ALSOVA - A 5-Year Alzheimer's Disease Fo...

Molecular Genetics of Alzheimer's Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, which affects up to 50% of individuals above the age of 85. Due to the global increase in the aging population, early diagnosis and treatment of AD are becoming increasingly important, not only from a human point...